Patents by Inventor Brian T. Kalet

Brian T. Kalet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating cancer with doxazolidine and prodrugs thereof
    Patent number: 8404650
    Abstract: The invention provides therapeutically effective compounds for the prevention and treatment of cancer and pharmaceutical compositions containing these compounds as well as methods of using and administering these compounds. The invention also includes methods of activating a prodrug of these therapeutically effective compounds by the administration of a peptide-directed targeting construct that delivers a prodrug-activating enzyme to a target activation site.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: March 26, 2013
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Tad H. Koch, David J. Burkhart, Glen C. Post, Jordan W. Nafie, Brian T. Kalet, Benjamin L. Barthel, Daniel L. Rudnicki
  • METHODS OF TREATING CANCER WITH DOXAZOLIDINE AND PRODRUGS THEREOF
    Publication number: 20110135618
    Abstract: The invention provides therapeutically effective compounds for the prevention and treatment of cancer and pharmaceutical compositions containing these compounds as well as methods of using and administering these compounds. The invention also includes methods of activating a prodrug of these therapeutically effective compounds by the administration of a peptide-directed targeting construct that delivers a prodrug-activating enzyme to a target activation site.
    Type: Application
    Filed: October 30, 2006
    Publication date: June 9, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: Tad H. Koch, David J. Burkhart, Glen C. Post, Jordan W. Nafie, Brian T. Kalet, Benjamin L. Barthel, Daniel L. Rudnicki